tirzepatide cardiovascular outcomes trial results july 2025 βοΈ Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes π BACKGROUND Tirzepatide, a dual incretin agonist of the glucagon-like peptide-1 and glucose-dependent Tirzepatide and cardiometabolic parameters in
Description
Building Behavioral Tools to Support Independence From Medication Successful discontinuation of GLP-1 therapy depends heavily on establishing durable lifestyle changes during your active treatment phase
Research Support, NonU.S
Limit high-sulfur foods High-sulfur foods, like garlic, onions, and cruciferous vegetables (e.g., cabbage and cauliflower), may cause sulfur burps
When the date arrives, discard any remaining solution
Less food means fewer opportunities to absorb B12 from dietary sources
